Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease
Marie‐Thérèse Armentero, Fabio Blandini(Unknown), Elisa Basso(Istituti di Ricovero e Cura a Carattere Scientifico), Claudio Pacchetti(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Giuseppe Nappi(University of Pavia), Giovanna Levandis(Istituti di Ricovero e Cura a Carattere Scientifico), Cristina Ghezzi(Istituti di Ricovero e Cura a Carattere Scientifico), E. Martignoni(University of Pavia), Emanuela Cova(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Debora Celi(Centro Neurolesi Bonino Pulejo), Roberta Zangaglia(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Giulia Ambrosi(University of Pavia), Elena Sinforiani(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Eleonora Bazzini(Istituti di Ricovero e Cura a Carattere Scientifico), Cristina Cereda(University of Milan)
Cited by 50
Related Papers
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
|Nature Genetics|2021|567
Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study
|The Lancet Neurology|2013|441
Active Music Therapy in Parkinson’s Disease: An Integrative Method for Motor and Emotional Rehabilitation
|Psychosomatic Medicine|2000|420